Building the Future of Brain Health
We built groundbreaking neuroscience ventures. From clinical validation to market-ready solutions, we partner with creators and investors to transform neurological health.
Bridge the gap between scientific research and real-world applications
52 Platform is a specialized venture builder that focuses on transforming neuroscience ideas into clinically validated market-ready innovations. We work with entrepreneurs to bring groundbreaking neurological solutions to life and partner with investors to fund these life-changing projects.
For Creators
Aimed at researchers, scientists, and entrepreneurs with innovative ideas in the field of neuroscience. We offer the clinical and business infrastructure necessary to develop and validate their projects.
For Investors
Providing investors with a secure and transparent platform to fund neuroscience ventures, offering carefully vetted projects with high growth potential in the neurological health sector.
We are driven by the need to improve brain health and neurological well-being for millions of people. 52 Platform was created to fast-track solutions for neurological conditions through a robust venture-building process, turning high-potential ideas into impactful real-world solutions. Our focus lies in building an ecosystem that supports not only entrepreneurs but also improves the lives of patients globally.
Patients Impacted
Over 95,000 patients across various neurological conditions have benefited from ventures fostered through our platform.
Specialized Practitioners
More than 110 specialized practitioners, from neurologists to technical experts, collaborate within our network to ensure that each venture is backed by clinical expertise
Neurological Centers
We have partnered with 15+ neurological centers globally, creating extensive opportunities for testing, research, and deployment of new solutions.
Public Grants
Through our ecosystem, we’ve successfully secured over $20 million in non-repayable public grants for our projects.
Capital Raised
The founding team has collectively raised over $3 billion across multiple ventures, demonstrating our ability to scale impactful projects.
Grant Success Rate
Our projects have a grant approval rate that is twice the industry average, showing our strength in delivering fundable, research-backed ventures.
Biotech Products for Neurological Health
We support projects with a structured process from concept to market validation. Our process includes:
Concept
We begin with ideas that emerge from validated, practitioner-backed needs in the neurological field.
Test Ground and Validation
Safe and extensive test grounds in Spain and LATAM allow us to validate new practices and devices, providing reliable test samples and real-world feedback.
Clinical Trial and Certification
Our team facilitates the step-by-step process, guiding ventures through clinical trials, obtaining certifications like CE and FDA, and aligning with fundraising goals.
We are launching 52 Platform Fund I, a $52 million USD fund aimed at investing in groundbreaking neuroscience ventures. This fund will focus on:
8 Proprietary Projects
15 External Projects
$2M Investment
52 Platform Fund I
52 Platform Fund I
Focused on innovative solutions from within our ecosystem, developed in collaboration with external entrepreneurs and creators, guiding them to market validation and scaling.